Clinical Trial Update: Efficacy and Safety of Liraglutide Versus Lixisenatide as add-on to Metformin in Subjects With Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial comparing liraglutide to lixisenatide as add-on therapy to metformin in adults with type 2 diabetes, reporting efficacy and safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Liraglutide (Victoza) (liraglutide)
• lixisenatide (Adlyxin) (lixisenatide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2015-12-22